News | December 23, 2023
Lupin Atlantis Holdings to acquire accretive established products in Europe and Canada from Sanofi
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
Total transaction value of the divestment is Rs. 3,660 million
This product will be manufactured at Lupin's Nagpur facility in India
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Lupin actively contributes to alleviating the burden of COPD for patients across the nation
Pratima takes on the role of Country Speaker in addition to her role as GM and MD of Merck Specialties in India
Intent to start at least 5 innovative Phase 3 vaccine programs by 2025
This product will be manufactured at Lupin's Pithampur facility in India
Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers in the territories of Europe, Australia and New Zealand. Philogen will complete pivotal clinical trials for the product in Europe
Subscribe To Our Newsletter & Stay Updated
